Drug Therapy for AUD May Cut Risk for Alcohol-Related Liver Disease
MONDAY, May 23, 2022 (HealthDay News) -- Receipt of medical addiction therapy for alcohol use disorder (AUD) is associated with a reduced incidence of alcohol-associated liver disease (ALD), according to a study published online May 20 in JAMA Network Open.
Augustin G. L. Vannier, from Massachusetts General Hospital in Boston, and colleagues conducted a retrospective cohort study to examine whether medical addiction therapy was associated with an altered risk for developing ALD in patients with AUD. The cohort included 9,635 patients with AUD (60.4 percent male; mean age, 54.8 years).
The researchers found that 11.8 percent of patients had ALD and 40.5 percent received medical addiction therapy. Medical addition therapy for AUD was associated with a reduced incidence of ALD in multivariable analyses (adjusted odds ratio [aOR], 0.37). The association was observed for naltrexone, gabapentin, topiramate, and baclofen (aORs, 0.67, 0.36, 0.47, and 0.57, respectively). In patients with cirrhosis, pharmacotherapy for AUD was associated with a reduced incidence of hepatic decompensation (aOR, 0.35), including naltrexone and gabapentin (aORs, 0.27 and 0.36, respectively). The association persisted even with initiation of medical addiction therapy after cirrhosis diagnosis (aOR, 0.41).
"Prospective randomized clinical trials are warranted to conclusively assess the benefits of both U.S. Food and Drug Administration-approved and off-label AUD pharmacotherapy as prophylaxis and treatment for ALD," the authors write.
Related Posts
BNT162b2 Prevents Critical COVID-19 in Children and Adolescents
MONDAY, April 4, 2022 (HealthDay News) -- For adolescents, vaccination provided...
La nueva variante ‘Mu’ del coronavirus se vigila de cerca, según Fauci
VIERNES, 3 de septiembre de 2021 (HealthDay News) -- Las autoridades de salud de...
In Early Days of Outbreak, Access to Mpox Vaccine Varied by Race
TUESDAY, April 11, 2023 (HealthDay News) -- In the early days of the mpox virus...
Recent Cancer May Increase Risk for Guillain-Barré Syndrome
FRIDAY, March 4, 2022 (HealthDay News) -- Recent cancer is associated with an...